1. Article | 2021.09.24

   Program analyzing the spread of the SARS-CoV-2 virus in high and low incidence areas of COVID-19 in Senegal

   Thanks to the support provided by the Fondation SUEZ, sero-epidemiological studies were launched by the Dakar Pasteur Institute in July 2020, as part of the fight against the SARS-CoV-19 pandemic. Thesse comparative studies on the prevalence of anti-SARS-COV-2 antibodies were conducted to better identify the risk factors associated with the spread of SARS-CoV-2 virus in populations resideing in...

2. Article | 2020.06.22

   Sequence the complete genome of Covid-19 directly and at low cost from prepared RNA samples from patients

   Aim: to be able to sequence the complete genome of Covid-19 directly and at low cost from prepared RNA samples from patients. We plan to implement a capture sequencing protocol targeting the SARS-CoV-2 genome using three commercial sets of probes in parallel. Results will be compared with a bioinformatics analysis pipeline and shared via publication (Biorxiv preprint followed by classical...

3. News | 2021.11.10

   COVID-19: Kamala Harris, Vice President of the United States, salutes the Institut Pasteur's response in tackling the pandemic

   As part of her trip to France for the fourth Paris Peace Forum – which includes three round tables on the challenges raised by the COVID-19 pandemic –, Kamala Harris, Vice President of the United States, visited the Institut Pasteur on November 9, 2021. She met several of the Institut Pasteur's scientists and saluted the unprecedented response of the Institut Pasteur's scientific community in...

4. News | 2020.12.07

   Unprecedented solidarity and support to accompany the member institutes of the International Network in the face of the COVID-19 pandemic

   The Institut Pasteur International Network, with the support of the International Department of the Institut Pasteur (Paris) and in association with institutional funders, has mobilised to help certain member institutes in Africa and Asia to carry out their public health missions in the context of the management of the COVID-19 pandemic.  The objective of this aid was to provide them with...

5. News | 2021.03.30

   Mobilization of the Institut Pasteur International Network to manage the COVID-19 outbreak: case study of support provided to the Institut Pasteur de Bangui

   Since the beginning of the COVID-19 pandemic, and increasingly rapidly thereafter, the Institut Pasteur International Network has drawn heavily on all its expertise and resources to tackle this emerging virus and its consequences, particularly through its support of institutes based in low-income countries. All Network member institutes have been identified by their health authorities as...

6. News | 2021.07.19

   COVID-19: interaction identified between SARS-CoV-2 and unusual RNA structures in human cells

   Replication of SARS-CoV-2, the virus responsible for COVID-19, depends on a series of interactions between viral proteins and different cellular partners such as nucleic acids (DNA or RNA). Characterizing these interactions is crucial to elucidate the process of viral replication and identify new drugs for treating COVID-19.An interdisciplinary consortium of scientists from the Institut Pasteur,...

7. News | 2021.08.13

   Low number of COVID-19 cases in Lao PTR: a seroprevalence study to confirm this figure

   In 2020 when many countries around the world struggled with a large burden of COVID-19 cases, the Lao PDR stood out as a country with low reported numbers of SARS-CoV-2 infections. Was it due to a low circulation of the virus or to an inadequate surveillance system? To answer this question, a seroprevalence study has been conducted by Institut Pasteur du Laos, in collaboration with Institut...

8. Document de presse | 2020.07.15

   Type 1 Interferon deficiency: A blood based Signature for Detecting Patients at risk of severe Covid-19 for a therapeutic approach

   Which patients will develop a severe form of Covid-19? This is a key question that needs to be answered to improve the individual management and prognosis of patients. In a study published in Science on July 13, teams from AP-HP, Inserm, Université of Paris, Institut Pasteur and Institut Imagine describe a unique and unexpected immunological phenotype in severe and critical patients, consisting...

9. Document de presse | 2020.04.30

   Revealing how SARS-CoV-2 hijacks human cells; points to drugs with potential to fight COVID-19 and a drug that aids its infectious growth

   An international effort including researchers from University of California San Francisco (UCSF), Gladstone Institutes, Icahn School of Medicine at Mount Sinai and Institut Pasteur (Paris) unveils promising compounds for clinical testing against COVID-19. The study, led by UCSF Quantitative Biosciences Institute Director, Nevan Krogan, PhD, reveals that some drugs may fight COVID-19...

10. News | 2021.02.05

    COVID-19 risk factors surveillance among healthcare workers: a study implemented by MediLabSecure Project

    According to the WHO recommendations, a multi-centre surveillance study has been implemented among healthcare workers in five African countries: Burkina Faso, Cameroon, Niger, Central African Republic and Madagascar. Coordinated by Institut Pasteur, this cohort study aims to identify the contamination risk factors and better understand the transmission/spread of the virus. The revue “...

Pages